INT230-6
intensity therapeutics
['intensity therapeutics']
our drug int23-6 data was just discussed and presented at #asco22 in live podium discussion session. dr. matthew ingham from columbia presbyterian was on the podium to answer questions from the audience.
Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.